- Home
- IFS vs APLS Comparison
IFS vs APLS Comparison
Compare IFS & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFS
- APLS
- Stock Information
- Founded
- IFS 1897
- APLS 2009
- Country
- IFS Peru
- APLS United States
- Employees
- IFS N/A
- APLS N/A
- Industry
- IFS Commercial Banks
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- IFS Finance
- APLS Health Care
- Exchange
- IFS Nasdaq
- APLS Nasdaq
- Market Cap
- IFS 3.3B
- APLS 3.6B
- IPO Year
- IFS 2019
- APLS 2017
- Fundamental
- Price
- IFS $31.72
- APLS $27.52
- Analyst Decision
- IFS Buy
- APLS Buy
- Analyst Count
- IFS 1
- APLS 18
- Target Price
- IFS $30.00
- APLS $46.71
- AVG Volume (30 Days)
- IFS 217.4K
- APLS 1.4M
- Earning Date
- IFS 02-05-2025
- APLS 02-28-2025
- Dividend Yield
- IFS 2.92%
- APLS N/A
- EPS Growth
- IFS 21.96
- APLS N/A
- EPS
- IFS 3.02
- APLS N/A
- Revenue
- IFS $1,189,396,011.00
- APLS $715,216,000.00
- Revenue This Year
- IFS N/A
- APLS $97.25
- Revenue Next Year
- IFS $9.67
- APLS $12.68
- P/E Ratio
- IFS $10.73
- APLS N/A
- Revenue Growth
- IFS 9.69
- APLS 162.10
- 52 Week Low
- IFS $20.56
- APLS $24.34
- 52 Week High
- IFS $33.62
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- IFS 56.54
- APLS 38.99
- Support Level
- IFS $31.93
- APLS $26.84
- Resistance Level
- IFS $32.82
- APLS $28.59
- Average True Range (ATR)
- IFS 0.79
- APLS 1.12
- MACD
- IFS -0.03
- APLS -0.03
- Stochastic Oscillator
- IFS 58.06
- APLS 18.09
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of financial services through banking, insurance, and wealth management businesses, as well as the recent integration of Izipay enhancing its payments ecosystem. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services, and Payments segment provides administration services, operation and processing of credit and debit cards. Its geographical segments include Peru and Panama.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.